
How Oryzon Genomics is using epigenetics to tackle cancer
DDW Editor Reece Armstrong speaks to Dr Carlos Buesa, Founder and CEO of Oryzon Genomics, about epigenetic approaches to treating cancer and the company’s current journey within drug discovery and development. RA: Can an epigenetic approach help tackle aggressive cancers and those with poor prognoses? CB: Yes. Many aggressive cancers are… Read More















